可靠的抗癌药物敏感性预测和优先考虑
Kerstin Lenhof1, Lea Eckhart2, Lisa-Marie Rolli2
1Center for Bioinformatics, Chair for Bioinformatics, Saarland Informatics Campus (E2.1) Saarland University, Campus, 66123, Saarbrücken, Saarland, Germany. klenhof@bioinf.uni-sb.de.
Scientific reports
|May 29, 2024
概括
这项研究引入了一种可靠的机器学习 (ML) 方法,用于预测抗癌药物敏感性. 该方法确保了用户指定的确定性水平,改善了癌症治疗中的风险减轻.
科学领域:
- 计算生物学 计算生物学
- 机器学习应用 机器学习应用
- 药物基因组学 药物基因组学
背景情况:
- 机器学习 (ML) 为现实世界解决问题提供了巨大的潜力,但也带来了固有的风险.
- 确保ML预测的可靠性,包括最小化模型错误和估计不确定性,对于降低风险至关重要,特别是在医疗应用中.
- 准确的抗癌药物敏感性预测对于有效的癌症治疗和药物开发至关重要.
研究的目的:
- 开发一种新的机器学习方法,可靠地预测和优先考虑抗癌药物敏感性.
- 为了保证临床应用的ML预测的用户指定的确定性水平.
- 引入一种新的药物敏感度指标,以根据临床相关性直接确定药物优先级.
主要方法:
- 开发了一种新的符合性预测方法,并应用于分类,回归和同时回归/分类任务.
- 该方法确保了用户指定的预测确定性水平,解决了ML可靠性的关键挑战.
- 通过使用临床相关的药物度制定了一种新的药物敏感度测量方法.
主要成果:
- 开发的方法提供可靠的抗癌药物敏感性预测,保证确定性.
- 合规预测框架是多功能,适用于不同的ML任务类型.
- 新型药物敏感性测量有助于对个别癌症样本进行高效和临床相关的药物优先排序.
结论:
- 提出的方法提高了在抗癌药物敏感性分析中ML预测的可靠性.
- 对于安全有效的临床决策来说,对ML预测的保证确定性水平至关重要.
- 新的药物敏感度测量和预测方法为个性化癌症治疗和药物发现提供了有前途的工具.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:21Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343